N. Dhir

Drug Repurposing and Orphan Disease Therapeutics

A. Prakash, B. Medhi, N. Dhir, 2020, Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications.

Pre-clinical to Clinical Translational Failures and Current Status of Clinical Trials in Stroke Therapy: A Brief Review

A. Prakash, B. Medhi, M. Goyal, 2020, Current neuropharmacology.

Aneurysmal Subarachnoid Hemorrhage: Impact on Phenytoin Permeability across the Blood–Brain Barrier

S. Attri, L. Saha, N. Dhir, 2020, Neurology India.

PERK inhibitor, GSK2606414, ameliorates neuropathological damage, memory and motor functional impairments in cerebral ischemia via PERK/p-eIF2ɑ/ATF4/CHOP signaling

B. Medhi, B. Radotra, A. Prakash, 2023, Metabolic Brain Disease.

Rat BM-MSCs secretome alone and in combination with stiripentol and ISRIB, ameliorated microglial activation and apoptosis in experimental stroke

B. Medhi, S. Bhattacharyya, S. Attri, 2023, Behavioural Brain Research.

Neuroprotective effect of bone marrow derived mesenchymal stem cell secretome in 6-OHDA-induced Parkinson's disease.

A. Prakash, B. Medhi, S. Bhattacharyya, 2021, Regenerative medicine.

“Comparative evaluation of different chemical agents induced Autism Spectrum Disorder in experimental Wistar rats”

B. Medhi, A. Bhatia, A. Prakash, 2023, Behavioural Brain Research.

Neuroprotective effect of 3,3'-diindolylmethane and ɑ-naphthoflavone, aryl hydrocarbon receptor modulators in an experimental model of ischemic stroke.

B. Medhi, A. Bhatia, A. Prakash, 2022, CNS & neurological disorders drug targets.